These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2132 related articles for article (PubMed ID: 28011833)

  • 1. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.
    Ma J; Guo L; Fiene SJ; Anson BD; Thomson JA; Kamp TJ; Kolaja KL; Swanson BJ; January CT
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2006-17. PubMed ID: 21890694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy.
    El-Battrawy I; Zhao Z; Lan H; Li X; Yücel G; Lang S; Sattler K; Schünemann JD; Zimmermann WH; Cyganek L; Utikal J; Wieland T; Bieback K; Bauer R; Ratte A; Pribe-Wolferts R; Rapti K; Nowak D; Wittig J; Thomas D; Most P; Katus HA; Ravens U; Schmidt C; Borggrefe M; Zhou XB; Müller OJ; Akin I
    Circ Genom Precis Med; 2018 Mar; 11(3):e001893. PubMed ID: 29545480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
    Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation.
    Zeng H; Wang J; Clouse H; Lagrutta A; Sannajust F
    Toxicol Sci; 2019 Feb; 167(2):573-580. PubMed ID: 30365015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human induced pluripotent stem cell-derived atrial cardiomyocytes recapitulate contribution of the slowly activating delayed rectifier currents IKs to repolarization in the human atrium.
    Sönmez MI; Goldack S; Nurkkala E; Schulz C; Klampe B; Schulze T; Hansen A; Eschenhagen T; Koivumäki J; Christ T
    Europace; 2024 Jun; 26(6):. PubMed ID: 38788213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.
    Wu J; Wang X; Chung YY; Koh CH; Liu Z; Guo H; Yuan Q; Wang C; Su S; Wei H
    PLoS One; 2017; 12(1):e0168435. PubMed ID: 28056022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
    Qu Y; Vargas HM
    Toxicol Sci; 2015 Sep; 147(1):286-95. PubMed ID: 26117837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.
    Sequiera GL; Mehta A; Ooi TH; Shim W
    Life Sci; 2013 Jan; 92(1):63-71. PubMed ID: 23142239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    El-Battrawy I; Lan H; Cyganek L; Zhao Z; Li X; Buljubasic F; Lang S; Yücel G; Sattler K; Zimmermann WH; Utikal J; Wieland T; Ravens U; Borggrefe M; Zhou XB; Akin I
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29574456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety pharmacology studies using EFP and impedance.
    Obergrussberger A; Juhasz K; Thomas U; Stölzle-Feix S; Becker N; Dörr L; Beckler M; Bot C; George M; Fertig N
    J Pharmacol Toxicol Methods; 2016; 81():223-32. PubMed ID: 27084108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Rocchetti M; Sala L; Dreizehnter L; Crotti L; Sinnecker D; Mura M; Pane LS; Altomare C; Torre E; Mostacciuolo G; Severi S; Porta A; De Ferrari GM; George AL; Schwartz PJ; Gnecchi M; Moretti A; Zaza A
    Cardiovasc Res; 2017 Apr; 113(5):531-541. PubMed ID: 28158429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
    Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
    PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.